The Pulse Magazine

Skip to content
The Pulse Magazine

The Archive

All Stories

Journeys, strategies and ideas from the people redefining business, leadership and innovation.

Jon Ward
Cover Story

Don't Ask What AI Can Do For You: Jon Ward on Why Transformation Fails in the Corridors, Not the Boardroom

Jon Ward has spent thirty years at the frontier of enterprise transformation as a management consultant, three-time Group CEO, Business Agility Ambassador, published author, and now, architect of governance frameworks for agentic AI. His central message to boards in 2026 is blunt: don't ask what AI can do for you. Ask what your business is actually for and only then ask which mechanism, human or machine, gets you there fastest without losing control of it.

Martie Smith
Cover Story

Reinvention Is Not a Destination: How Martie M. Smith Turned a Lifetime of Change Into a Mission of Resilience

Martie M. Smith has been a mechanic, a U.S. Air Force veteran, a radiation therapist, a STEM educator, a furniture builder, a photographer, an award-winning bilingual author, and a global mentor. On paper, it reads like someone who couldn't settle. In practice, it's the story of someone who kept learning to begin again — and built a life's mission out of teaching others to do the same.

Rebecca Sacks
Cover Story

How Rebecca Sacks Is Proving the Best Growth Strategy Starts With the Right Hire

There is a version of leadership most people learn first, the one built on hierarchy, control, and being served. Rebecca Sacks, Founder & Principal Consultant of Authentic Talent Edge, built her 20+ year career proving there's a better one. In this exclusive Pulse Magazine feature, she breaks down why talent acquisition is the most under-leveraged growth lever in business, what AI can never replace in recruiting, and why the organizations that treat hiring as a human experience, not a process and are the ones that build lasting, high-performing teams.

Cochrane review anti-amyloid Alzheimer's drugs Leqembi Kisunla trivial effects 2026
Health & Wellness

Anti-Amyloid Alzheimer’s Drugs Face New Doubts: Cochrane Review Finds ‘Trivial’ Effects

A bombshell Cochrane review questions the effectiveness of anti-amyloid Alzheimer’s drugs like Leqembi and Kisunla, calling their benefits “absent or trivial” despite FDA approvals. Cochrane Analysis: Little to No Clinical Benefit The nonprofit Cochrane compiled data from 17 placebo-controlled studies on seven amyloid-beta-targeting monoclonal antibodies, involving over 20,000 people with mild cognitive impairment or mild Alzheimer’s dementia.

Reed Hastings Netflix co-founder board chair departure 2026
News

Reed Hastings Steps Down as Netflix Board Chair: What It Means for Investors in 2026

Reed Hastings, the legendary co-founder and longtime chair of Netflix, is stepping down from the board in June 2026. This news comes as Netflix reports strong Q1 earnings and moves on from its failed $72 billion Warner Bros Discovery acquisition. Netflix Confirms No Disagreements in Reed Hastings Departure In an SEC filing and shareholder letter